R&D
ANGLE’s Parsortix system used in new cancer biology research
June 10, 2025Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals
ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …
Moderna expands use of AI-ready R&D platform
May 12, 2025Business Services, Research and Development, Technical Consultancy AI, Benchling, Corporate, Moderna, R&D, digital transformation
Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …
Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases
May 9, 2025Research and Development Galimedix Therapeutics, Neurology, Opthalmology, R&D, clinical trial, neurodegenerative conditions
Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study …
Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease
April 8, 2025Research and Development R&D, Rare Diseases, Scottish Medicines Consortium, ipsen, primary biliary cholangitis (PBC)
The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS Scotland for the treatment of …
ELRIG appoints Del Trezise as chair
April 8, 2025Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma
ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …
AbbVie invests €150m in new R&D facility in Germany
May 3, 2024Research and Development AbbVie, Pharmacy, R&D, facility
AbbVie has announced that it is investing approximately €150m in its second largest research and development (R&D) facility worldwide. The …
Evotec and Dewpoint Therapeutics enter strategic partnership
November 7, 2023Research and Development Dewpoint Therapeutics, Evotec, Oncology, R&D, oncology
Evotec and Dewpoint Therapeutics have announced a strategic R&D collaboration for the advancement of Dewpoint’s oncology pipeline programmes of condensate …
BMS shares new research and development  plans at the company’s R&D day
September 15, 2023Research and Development BMS, Pharmacy, R&D, development, research
Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, US, in order to discuss …
UK industry spend on R&D collaborations grows to £377.3 million
July 2, 2019Manufacturing and Production, Medical Communications, Research and Development ABPI, R&D, pharma
The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations …
Sobi acquire Novimmune in deal worth more than £400 million
June 13, 2019Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma
Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …
Dr Dietmar Berger returns to big pharma
May 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research
Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …
ICR calls for faster access to innovative cancer drugs
April 25, 2019Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing
The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …
GSK to make redundancies at plant in Stevenage
April 17, 2019Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
Reckitt Benckiser to unveil £105 R&D site in Hull by end of June
April 11, 2019Manufacturing and Production Hull, R&D, Reckitt Benckiser, UK, pharma
Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …
Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease
March 21, 2019Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia
Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …
